Healthcare Economist |
NICE’s new Severity Adjustment Posted: 27 Feb 2022 03:03 PM PST In the United Kingdom, the National Institute for Health and Care Excellence (NICE) made an update to their health technology evaluations manual in January 2022. Of particular interest, section 6.2 of the manual states that the review committee "will consider the associated absolute and proportional QALY shortfall." The committee defined QALY shortfall two ways:
Once the proportional and absolute QALY shortfalls are calculated, NICE has proposed using specific QALY weightings as described in the table below. NICE intends to apply the severity multiplier only to therapeutic health technologies, but not diagnostic health technologies. ![]() NICE also may consider increase in QALY weightings for highly specialized technologies (HST) with large incremental gains in QALY as measured over the lifetime time horizon of a new technology. The table below describes how these will be applied. While the application of these weightings is highly mechanical, identifying the shortfalls requires data analysis on the counterfactual of what the QALYs would be in the absence of disease ![]() These two modifications aim to address two violations of constant QALY valuations as identified in |
You are subscribed to email updates from Healthcare Economist. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States |
No comments:
Post a Comment